Abstract
Triptolide, a major component in the extract of Chinese herbal plant Tripterygium wilfordii Hook f (TWHf), has potential anti-neoplastic effect. In the present study we investigated the potential therapeutic effects and mechanisms of triptolide against human gastric cancer cells. Four gastric cancer cell lines with different p53 status, AGS and MKN-45 (wild type p53); MKN-28 and SGC-7901 (mutant p53) were observed as to cell growth inhibition and induction of apoptosis in response to triptolide treatment. We showed that triptolide inhibited cell growth, induced apoptosis and suppressed NK-κB and AP-1 transactivation in AGS cells with wild-type p53. Triptolide induced apoptosis by stimulating the expressions of p53, p21waf1/cip1, bax protein, and increased the activity of caspases. In addition, it caused cell cycle arrest in the G0/G1 phase. To examine the role of p53 in these functions, we showed that suppression of p53 level with antisense oligonucleotide abrogated triptolide-induced apoptosis and over-expression of dominant negative p53 abolished the inhibitory effect on NF-κB activation. Furthermore, we demonstrated that triptolide had differential effects on gastric cancer cells with different p53 status. We showed that triptolide also inhibited cell growth and induced apoptosis in MKN-45 with wild-type p53, whereas it had no significant growth-inhibition and apoptosis induction effects on the MKN-28 and SGC-7901 cells with mutant p53. Our data suggest that triptolide exhibits anti-tumor and anti-inflammatory effects by inhibiting cell proliferation, inducing apoptosis and inhibiting NF-κB and AP-1 transcriptional activity. However, a functional p53 is required for these proapoptotic, anti-inflammatory and anti-tumor effects.
Similar content being viewed by others
Abbreviations
- TWHf:
-
Tripterygium wilfordii Hook f
- NF-κB:
-
nuclear factor-κB
- AP-1:
-
Activator Protein-1
References
Amundson SA, Myers TG, Fornace AJ . 1998 Oncogene 17: 3287–3299
Angel P, Baumann I, Stein B, Delius H, Rahmsdorg HJ, Herrlich P . 1987 Mol. Cell. Biol. 7: 2256–2266
Angel P, Karin M . 1991 Biochem. Biophys. Acta. 1072: 129–157
Calvert AH, Ghokul S, Al-Azraqi A, Wright J, Lind M, Bailey N . 1999 Semin. Oncol. 16: S90–S94
Chang WT, Kang JJ, Lee KY, Wei K, Anderson E, Gormare S, Ross JA, Rosen GD . 2001 J. Biol. Chem. 276: 2221–2227
Dignam JD, Lebovitz RM, Roeder RG . 1983 Nucleic Acids Res. 11: 1475–1489
El-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, Pietenpol JA, Burrell M, Hill DE, Wang Y, Wiman KG, Mercer WE, Kastan MB, Kohn KW, Elledge SJ, Kinzler KW, Vogelstein B . 1994 Cancer Res. 54: 1169–1174
El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B . 1993 Cell. 75: 817–825
Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C . 1992 Nature 358: 83–86
Grant S, Jarvis WD, Swerdlow PS, Turner AJ, Traylor RS, Wallace HJ, Lin PS, Pettit GR, Gewirtz DA . 1992 Cancer Res. 52: 6270–6278
Jiang X . 1994 Pediatr. Nephrol. 8: 343–344
Kobayashi T, Consoli U, Andreeff M, Shiku H, Zhang W . 1995 Oncogene 11: 2311–2316
Kupchan SM, Court WA, Dailey RG, Gilmore CJ, Bryan RF . 1972 Amer. Chem. Soc. 94: 7194–7195
Lane DP . 1992 Nature 358: 15–16
Lee JM, Bernstein A . 1995 Cancer Metastasis Rev. 14: 149–161
Lee KY, Chang WT, Qiu DM, Kao PM, Rosen GD . 1999 J. Biol. Chem. 274: 13451–13455
Li JJ, Westergaad D, Ghosh P, Colburn NH . 1997 Cancer Res. 57: 3569–3576
Linke SP, Clarkin KC, Wahl GM . 1997 Cancer Res. 57: 1171–1179
Lowe SW, Ruley HE, Jacks T, Housman DE . 1993 Cell 74: 957–967
Midgley CA, Owens B, Briscoe CV, Thomas DB, Lane DP, Hall PA . 1995 J. Cell Sci. 108: 1843–1848
Miyashita T, Reed JC . 1995 Cell 80: 293–299
Müller H, Eppenberger U . 1996 Anticancer Res. 16: 3845–3848
Nishizaki M, Roth JA, Tanaka N . 2000 Oncogene 19: 726–736
Patel T, Gores GJ, Kaufmann SH . 1996 FASEB J. 10: 587–597
Penninger JM, Kroemer G . 1996 Adv. Immunol. 68: 51–144
Pu LX, Zhang TM . 1990 Acta. Pharmacologica Sinica. 11: 76–79
Qin WZ, Liu CH, Yang SM . 1981 Chin. Med. J. (Engl.) 94: 827–830
Qiu D, Zhao G, Aoki Y, Shi L, Uyei A, Nazarian S, Ng JC, Kao PN . 1999 J. Biol. Chem. 274: 13443–13450
Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J . 1992 Proc. Natl. Acad. Sci. USA 89: 4495–4499
Tao X, Sun Y, Dong Y, Xiao YL, Hu DW, Shi YP, Zhu QL, Huan D, Zhang NZ . 1989 Chin. Med. J. (Engl.) 102: 327–332
Tetu B, Brisson J, Plante V, Bernard P . 1998 Mod. Pathol. 11: 823–830
Vasey PA, Jones NA, Jenkins S, Dive C, Brown R . 1996 Mol. Pharmacol. 50: 1536–1540
Wang D, Baldwin AS . 1998 J. Biol. Chem. 273: 29411–29416
Webster GA, Perkins ND . 1999 Mol. Cell. Biol. 19: 3485–3495
Wei YS, Adachi L . 1991 Acta. Pharmacologica Sinica. 12: 406–410
Weller M . 1998 Cell Tissue Res. 292: 435–445
Yang SX, Gao HL, Xie SS, Zhang WR, Long ZZ . 1992 Int. J. Immunopharmacol. 14: 963–969
Yang Y, Liu Z, Tolosa E, Yang J, Li L . 1998 Immunopharmacology 40: 139–149
Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M . 1991 Nature 352: 345–347
Zhao G, Vaszar LT, Qiu D, Shi L, Kao PN . 2001 Am. J. Physiol. Lung Cell Mol. Physiol. 279: L958–L966
Zhan Q, Alamo I, Yu K, Boise LH, Cherney B, Tosato G, O'Connor PM, Fornace AJ . 1996 Oncogene 13: 2287–2293
Zhang LX, Yu FK, Zhang QY, Fang Z, Pan DJ . 1990 Acta. Pharmaceutica Sinica. 25: 573–577
Zhong H, Voll RE, Ghosh S . 1998 Mol. Cell. Biol. 1: 661–671
Zhu GH, Wong BC, Eggo MC, Yuen ST, Lai KC, Lam SK . 1999 Dig. Dis. Sci. 44: 2020–2026
Zhu GH, Wong BC, Slosberg ED, Eggo MC, Ching CK, Yuen ST, Lai KC, Soh JW, Weinstein IB, Lam SK . 2000 Gastroenterology 118: 507–514
Acknowledgements
This study is supported by Gastroenterological Research Fund, University of Hong Kong.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jiang, XH., Wong, BY., Lin, MM. et al. Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-κB activation in gastric cancer cells. Oncogene 20, 8009–8018 (2001). https://doi.org/10.1038/sj.onc.1204981
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204981
- Springer Nature Limited
Keywords
This article is cited by
-
Advance on toxicity of metal nickel nanoparticles
Environmental Geochemistry and Health (2020)
-
Triptolide inhibits Epstein-Barr nuclear antigen 1 expression by increasing sensitivity of mitochondria apoptosis of nasopharyngeal carcinoma cells
Journal of Experimental & Clinical Cancer Research (2018)
-
C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells
Journal of Experimental & Clinical Cancer Research (2018)
-
Demethylzeylasteral inhibits glioma growth by regulating the miR-30e-5p/MYBL2 axis
Cell Death & Disease (2018)
-
BRD4 regulates cellular senescence in gastric cancer cells via E2F/miR-106b/p21 axis
Cell Death & Disease (2018)